The SameSpots software provides significant improvements in speed, objectivity and statistical power. This is said to make a radical impact on proteomics research by giving customers both the facility to know how many biological replicates they need to run and the speed to make it feasible to run that many replicates, thus allowing scientists to draw valid conclusions about the biology being studied.
Leighton Smith, CEO of UVP, said: “The combination of the BioSpectrum 800 with SameSpots offers a fast yet affordable option for researchers.”